137 related articles for article (PubMed ID: 35134590)
1. Oral mucosal melanoma - A systematic review.
Thuaire A; Nicot R; Boileau M; Raoul G; Descarpentries C; Mouawad F; Germain N; Mortier L; Schlund M
J Stomatol Oral Maxillofac Surg; 2022 Oct; 123(5):e425-e432. PubMed ID: 35134590
[TBL] [Abstract][Full Text] [Related]
2. Determining the epidemiologic, outcome, and prognostic factors of oral malignant melanoma by using the Surveillance, Epidemiology, and End Results database.
Lee RJ; Lee SA; Lin T; Lee KK; Christensen RE
J Am Dent Assoc; 2017 May; 148(5):288-297. PubMed ID: 28325493
[TBL] [Abstract][Full Text] [Related]
3. NRAS and BRAF mutation frequency in primary oral mucosal melanoma.
Buery RR; Siar CH; Katase N; Gunduz M; Lefeuvre M; Fujii M; Inoue M; Setsu K; Nagatsuka H
Oncol Rep; 2011 Oct; 26(4):783-7. PubMed ID: 21750866
[TBL] [Abstract][Full Text] [Related]
4. The existence of early stage oral mucosal melanoma: A 10-year retrospective analysis of 170 patients in a single institute.
Wu Y; Wang L; Ma X; Guo W; Ren G
Oral Oncol; 2018 Dec; 87():70-76. PubMed ID: 30527246
[TBL] [Abstract][Full Text] [Related]
5. Oral Mucosal Melanoma.
Nisi M; Izzetti R; Gennai S; Pucci A; Lenzi C; Graziani F
J Craniofac Surg; 2022 May; 33(3):830-834. PubMed ID: 34334749
[TBL] [Abstract][Full Text] [Related]
6.
Chen F; Zhang Q; Wang Y; Wang S; Feng S; Qi L; Li X; Ding C
Oncol Lett; 2018 Jun; 15(6):9786-9792. PubMed ID: 29805686
[TBL] [Abstract][Full Text] [Related]
7. Mutational landscape of oral mucosal melanoma based on comprehensive cancer genomic profiling tests in a Japanese cohort.
Ichimura N; Urata Y; Kobayashi T; Hibi H
Oral Oncol; 2024 May; 152():106807. PubMed ID: 38615585
[TBL] [Abstract][Full Text] [Related]
8. Treatment and prognosis of oral mucosal melanoma.
Sun CZ; Chen YF; Jiang YE; Hu ZD; Yang AK; Song M
Oral Oncol; 2012 Jul; 48(7):647-52. PubMed ID: 22349277
[TBL] [Abstract][Full Text] [Related]
9. BRAF, NRAS, KIT, TERT, GNAQ/GNA11 mutation profile analysis of head and neck mucosal melanomas: a study of 42 cases.
Öztürk Sari Ş; Yilmaz İ; Taşkin OÇ; Narli G; Şen F; Çomoğlu Ş; Firat P; Bİlgİç B; Yilmazbayhan D; Özlük Y; Büyükbabanİ N
Pathology; 2017 Jan; 49(1):55-61. PubMed ID: 27914687
[TBL] [Abstract][Full Text] [Related]
10. Neck dissection and post-operative chemotherapy with dimethyl triazeno imidazole carboxamide and cisplatin protocol are useful for oral mucosal melanoma.
Yang X; Ren GX; Zhang CP; Zhou GY; Hu YJ; Yang WJ; Guo W; Li J; Zhong LP
BMC Cancer; 2010 Nov; 10():623. PubMed ID: 21070637
[TBL] [Abstract][Full Text] [Related]
11. Primary oral mucosal melanoma: advocate a wait-and-see policy in the clinically N0 patient.
Wang X; Wu HM; Ren GX; Tang J; Guo W
J Oral Maxillofac Surg; 2012 May; 70(5):1192-8. PubMed ID: 21783300
[TBL] [Abstract][Full Text] [Related]
12. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
Larsen AC
Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
[TBL] [Abstract][Full Text] [Related]
13. Mutation scanning of BRAF, NRAS, KIT, and GNAQ/GNA11 in oral mucosal melanoma: a study of 57 cases.
Lyu J; Wu Y; Li C; Wang R; Song H; Ren G; Guo W
J Oral Pathol Med; 2016 Apr; 45(4):295-301. PubMed ID: 26399561
[TBL] [Abstract][Full Text] [Related]
14. Oral mucosal melanoma in four Nigerian teaching hospitals.
Nwoga MC; Effiom OA; Adeyemi BF; Soyele OO; Okwuosa CU
Niger J Clin Pract; 2019 Dec; 22(12):1752-1757. PubMed ID: 31793484
[TBL] [Abstract][Full Text] [Related]
15. Clinics, prognosis and new therapeutic options in patients with mucosal melanoma: A retrospective analysis of 75 patients.
Schaefer T; Satzger I; Gutzmer R
Medicine (Baltimore); 2017 Jan; 96(1):e5753. PubMed ID: 28072717
[TBL] [Abstract][Full Text] [Related]
16. Mucosal Melanoma: Epidemiology, Clinical Features, and Treatment.
Sergi MC; Filoni E; Triggiano G; Cazzato G; Internò V; Porta C; Tucci M
Curr Oncol Rep; 2023 Nov; 25(11):1247-1258. PubMed ID: 37773078
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological features and clinical outcomes associated with TP53 and BRAF
Kim DW; Haydu LE; Joon AY; Bassett RL; Siroy AE; Tetzlaff MT; Routbort MJ; Amaria RN; Wargo JA; McQuade JL; Kemnade J; Hwu P; Woodman SE; Roszik J; Kim KB; Gershenwald JE; Lazar AJ; Davies MA
Cancer; 2017 Apr; 123(8):1372-1381. PubMed ID: 27911979
[TBL] [Abstract][Full Text] [Related]
18. A primary oral mucosal melanoma of the hard palate with no recurrence: Report of a 10 years follow-up.
Correia-Neto IJ; Correa MB; Araújo ALD; Penafort PVM; Colafemina ACE; Elias RA; Santos-Silva AR; Vargas PA; Lopes MA
Spec Care Dentist; 2024; 44(3):751-755. PubMed ID: 37814400
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and outcomes with specific BRAF and NRAS mutations in patients with metastatic melanoma.
Bucheit AD; Syklawer E; Jakob JA; Bassett RL; Curry JL; Gershenwald JE; Kim KB; Hwu P; Lazar AJ; Davies MA
Cancer; 2013 Nov; 119(21):3821-9. PubMed ID: 23922205
[TBL] [Abstract][Full Text] [Related]
20. Mutational Status of NRAS and BRAF Genes and Protein Expression Analysis in a Series of Primary Oral Mucosal Melanoma.
Hsieh R; Nico MM; Camillo CM; Oliveira KK; Sangueza M; Lourenço SV
Am J Dermatopathol; 2017 Feb; 39(2):104-110. PubMed ID: 28134726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
